Cargando…

Biomarkers in Early Response to Brolucizumab on Pigment Epithelium Detachment Associated with Exudative Age-Related Macular Degeneration

Background: The purpose of this study was to describe early changes in the morphology of pigment epithelium detachments (PED) after an intravitreal injection of Brolucizumab into eyes with macular neovascularization secondary to exudative age-related macular degeneration (e-AMD). Method: We included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rispoli, Marco, Eandi, Chiara M., Di Antonio, Luca, Kilian, Raphael, Montesel, Andrea, Savastano, Maria C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230427/ https://www.ncbi.nlm.nih.gov/pubmed/34200829 http://dx.doi.org/10.3390/biomedicines9060668

Ejemplares similares

Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice
por: Montesel, Andrea, et al.
Publicado: (2021)

Brolucizumab for macular degeneration
Publicado: (2020)

Treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration
por: Gonzalez, Andres, et al.
Publicado: (2017)

INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE FOR MACULAR HOLE COEXISTENT WITH RHEGMATOGENOUS RETINAL DETACHMENT
por: Stappler, Theodor, et al.
Publicado: (2022)

Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
por: Garweg, Justus G., et al.
Publicado: (2023)

Subretinal Pigment Epithelium Illumination Combined With Focal Electroretinogram and Visual Acuity for Early Diagnosis and Prognosis of Non-Exudative Age-Related Macular Degeneration: New Insights for Personalized Medicine
por: Savastano, Maria Cristina, et al.
Publicado: (2022)

Slow progression of exudative age related macular degeneration associated with hypertrophy of the retinal pigment epithelium
por: Stern, Jeffrey, et al.
Publicado: (2014)

Evaluation of retinal pigment epithelium changes in serous pigment epithelial detachment in age-related macular degeneration
por: Miura, Masahiro, et al.
Publicado: (2021)

Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
por: Panos, Georgios D, et al.
Publicado: (2013)

Comparison of the regressive effects of aflibercept and brolucizumab on pigment epithelial detachment
por: Mukai, Ryo, et al.
Publicado: (2022)

TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration
por: Montesel, Andrea, et al.
Publicado: (2022)

Response of extra-large pigment epithelial detachment to intravitreal brolucizumab injection
por: Chakraborty, Somnath, et al.
Publicado: (2023)

Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration
por: Mattes, Dietmar, et al.
Publicado: (2009)

Serous Pigment Epithelium Detachment Associated with Age-Related Macular Degeneration: A Possible Treatment Approach
por: V. Pasyechnikova, Nataliya, et al.
Publicado: (2012)

Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections
por: Gigon, Anthony, et al.
Publicado: (2022)

Retinal Pigment Epithelial Detachment in Age-Related Macular Degeneration
por: Karampelas, Michael, et al.
Publicado: (2020)

Bilateral blindness after uneventful brolucizumab injection for macular degeneration
por: Barchichat, Ilan, et al.
Publicado: (2022)

Brolucizumab for Neovascular Age-Related Macular Degeneration (BEL Study)
por: Van Cleemput, Liesbeth, et al.
Publicado: (2023)

A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
por: Kikushima, Wataru, et al.
Publicado: (2023)

Short-term Efficacy and Safety of Intravitreal Brolucizumab Injection for Treatment-Naive Exudate Age-related Macular Degeneration: A Multicenter Study
por: Kim, Juno, et al.
Publicado: (2023)

Retinal pigment epithelium hyperplasia overlying pigment epithelial detachment in age-related macular degeneration can masquerade as neovascularization on optical coherence tomography angiography
por: Chen, Ling, et al.
Publicado: (2018)

Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
por: Yannuzzi, Nicolas A, et al.
Publicado: (2019)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration
por: Musiał-Kopiejka, Magdalena, et al.
Publicado: (2022)

Treatment of large avascular retinal pigment epithelium detachments in age-related macular degeneration with aflibercept, photodynamic therapy, and triamcinolone acetonide
por: Tvenning, Arnt-Ole, et al.
Publicado: (2019)

Response to brolucizumab treatment for refractory serous pigment epithelial detachment secondary to polypoidal choroidal vasculopathy
por: Nam, Seung Wan, et al.
Publicado: (2022)

Enriched environment and visual stimuli protect the retinal pigment epithelium and photoreceptors in a mouse model of non-exudative age-related macular degeneration
por: Dieguez, Hernán H., et al.
Publicado: (2021)

Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections
por: Savastano, Maria Cristina, et al.
Publicado: (2021)

Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: significant association of twelve variants
por: Cascella, Raffaella, et al.
Publicado: (2017)

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
por: Maggio, Emilia, et al.
Publicado: (2022)

Concise Review: Update on Retinal Pigment Epithelium Transplantation for Age‐Related Macular Degeneration
por: Zarbin, Marco, et al.
Publicado: (2019)

Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Correlation with Macular Function
por: Savastano, Maria C., et al.
Publicado: (2020)

Activated Retinal Pigment Epithelium, an Optical Coherence Tomography Biomarker for Progression in Age-Related Macular Degeneration
por: Curcio, Christine A., et al.
Publicado: (2017)

Familial exudative vitreoretinopathy complicated with macular hole retinal detachment
por: Singh, Priyanka, et al.
Publicado: (2023)

Early OCT Angiography Changes of Macular Neovascularization in Patients with Exudative AMD Treated with Brolucizumab in a Real-World Setting
por: Rübsam, Anne, et al.
Publicado: (2022)

OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
por: Khanani, Arshad M., et al.
Publicado: (2018)

Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration
por: Selvam, Amrish, et al.
Publicado: (2023)

NLRP3 Upregulation in Retinal Pigment Epithelium in Age-Related Macular Degeneration
por: Wang, Yujuan, et al.
Publicado: (2016)

Molecular Mechanisms of Retinal Pigment Epithelium Dysfunction in Age-Related Macular Degeneration
por: Kim, Jongmin, et al.
Publicado: (2021)

Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration
por: Senabouth, Anne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b46rmal59q6bklk1utckvl75qc